Experts and Doctors on neoplasms in Perth, Western Australia, Australia


Locale: Perth, Western Australia, Australia
Topic: neoplasms

Top Publications

  1. Fritschi L, Glass D, Heyworth J, Aronson K, Girschik J, Boyle T, et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses. 2011;77:430-6 pubmed publisher
  2. Norman R, Viney R, Aaronson N, Brazier J, Cella D, Costa D, et al. Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Qual Life Res. 2016;25:637-49 pubmed publisher
    ..A DCE valuation task in which only four of the QLU-C10D's ten dimensions differed in any choice set is feasible for deriving utility weights for the QLU-C10D. ..
  3. Gross I, Trentino K, Andreescu A, Pierson R, Maietta R, Farmer S. Impact of a Patient Blood Management Program and an Outpatient Anemia Management Protocol on Red Cell Transfusions in Oncology Inpatients and Outpatients. Oncologist. 2016;21:327-32 pubmed publisher
    ..Despite the decreased use of ESA therapy, the implementation of a PBM program and outpatient anemia management protocol in cancer patients at our medical center was associated with significant reductions in RBC usage. ..
  4. Fritschi L, Hoving J, Sim M, Del Monaco A, MacFarlane E, McKenzie D, et al. All cause mortality and incidence of cancer in workers in bauxite mines and alumina refineries. Int J Cancer. 2008;123:882-7 pubmed publisher
    ..This study is the first to examine cancer and mortality amongst workers in bauxite mines and alumina refineries and found little evidence for increased cancer incidence or mortality in these workers. ..
  5. Manzur M, Hamzah J, Ganss R. Modulation of g protein signaling normalizes tumor vessels. Cancer Res. 2009;69:396-9 pubmed publisher
    ..Here, we consider the implications of these findings, and how they contribute to enhancing our understanding of remodeling angiogenic vessels as means for improving anticancer therapies. ..
  6. Surana R, Sikka S, Cai W, Shin E, Warrier S, Tan H, et al. Secreted frizzled related proteins: Implications in cancers. Biochim Biophys Acta. 2014;1845:53-65 pubmed publisher
    ..However, little is known about SFRP family members and their role in different cancers. This review comprehensively covers all the available information on the role of SFRP molecules in various human cancers. ..
  7. Jiwa M, Halkett G, Aoun S, Arnet H, Smith M, Pilkington M, et al. Factors influencing the speed of cancer diagnosis in rural Western Australia: a General Practice perspective. BMC Fam Pract. 2007;8:27 pubmed
  8. Grape S, Schug S, Lauer S, Schug B. Formulations of fentanyl for the management of pain. Drugs. 2010;70:57-72 pubmed publisher
    ..Overall, the specific pharmacological and physicochemical properties of fentanyl have made this compound highly suitable for novel routes of administration in a range of clinical indications. ..
  9. Khong A, Nelson D, Nowak A, Lake R, Robinson B. The use of agonistic anti-CD40 therapy in treatments for cancer. Int Rev Immunol. 2012;31:246-66 pubmed publisher

More Information


  1. Singh F, Newton R, Galv√£o D, Spry N, Baker M. A systematic review of pre-surgical exercise intervention studies with cancer patients. Surg Oncol. 2013;22:92-104 pubmed publisher
    ..Surgical oncologists may consider pre-surgical exercise interventions as a potential adjuvant therapy to improve patients' outcomes. ..
  2. Breen L, O Connor M. Rural health professionals' perspectives on providing grief and loss support in cancer care. Eur J Cancer Care (Engl). 2013;22:765-72 pubmed publisher
    ..The findings have implications in enhancing the loss and grief support services available in rural, regional, and remote Western Australia, including those grieving the death of a loved one through cancer. ..
  3. Finlay J, Wyatt K, Black M. Evaluation of the risks of chemotherapy in dogs with thrombocytopenia. Vet Comp Oncol. 2017;15:151-162 pubmed publisher
    ..028). The results presented here showed no evidence for an increased risk of gastrointestinal adverse effects or haemorrhage in thrombocytopenic dogs after receiving standard doses of chemotherapy. ..
  4. Cook A, Lesterhuis W, Nowak A, Lake R. Chemotherapy and immunotherapy: mapping the road ahead. Curr Opin Immunol. 2016;39:23-9 pubmed publisher
  5. Anderson D, Seib C, Tjondronegoro D, Turner J, Monterosso L, McGuire A, et al. The Women's wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol. BMC Cancer. 2017;17:98 pubmed publisher
    ..The protocol for this study was registered with the Australian and New Zealand Clinical Trials Registry, Trial ID: ACTRN12614000800628 , July 28, 2014. ..
  6. Haycock P, Burgess S, Nounu A, Zheng J, Okoli G, Bowden J, et al. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol. 2017;3:636-651 pubmed publisher
    ..28-0.61]) and interstitial lung disease (OR, 0.09 [95% CI, 0.05-0.15]). It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases. ..